All In MedTech

Device Trial Radar · NCT07186725

Home-based Under Mattress Monitor for OSA

Home-Based Under-Mattress Monitoring Device to Estimate Mandibular Advancement in Oral Appliance Therapy for Obstructive Sleep Apnea

Last checked: Nov 19, 2026Latest source record: Feb 3, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

70

Planned (sponsor's estimate)

Start

Jan 7, 2026

Primary completion

Mar 2027

Study completion Mar 2027

Sponsor

Lead sponsor
Isabel Moreno HayAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
American Academy of Dental Sleep Medicine
First posted
Sep 22, 2025

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Diagnostic
FDA-regulated device
Yes
Who can join
All sexes, from 18 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The aim of the study is to evaluate the effectiveness of the under-mattress monitoring device to aid in the titration process of a mandibular advancement device (MAD) for the management of obstructive sleep apnea (OSA). A secondary aim is to evaluate changes in subjective OSA symptoms and patient's satisfaction with MAD. A third aim is to analyze if there are differences between the sleep parameters recorded by the under-mattress monitor between responders and non-responders to MAD therapy.

Conditions

  • Obstructive Sleep Apnea (OSAS)
  • Obstructive Sleep Apnea (SAOS)

Interventions

  • Under-mattress monitorDevice

    the under-mattress monitor will be used in conjunction with the Alice NightOne at the beginning and end of the study, in addition, the under-mattress monitor will be used daily during sleep with the intraoral device in situ

  • level 3 Home Sleep Apnea TestDevice

    Home sleep apnea test with Alice NightOne will be used for one day during sleep at the beginning and end of the study in conjunction with the Sleeptracker AI and the intraoral device.

  • Mandibular Advancement Device (MAD)Device

    CAD-CAM, US Food and Drug Administration (FDA)-approved MAD, duo-bloc, customized, titratable sleep appliance. Participants will return every 2 weeks to the Orofacial Pain (OFP) clinic to progressively titrate the MAD advancement as needed until the under-mattress monitor scores an AHI \< 5

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change in apnea-hypopnea index (AHI).Time frame: Baseline and post-intervention (approximately 12 weeks)
  2. Change in minimum oxygen desaturation levelTime frame: Baseline and post-intervention (approximately 12 weeks)

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • University of Kentucky

    Lexington, Kentucky · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.